Prostate-Specific Antigen Progression Predicts Overall Survival in Patients With Metastatic Prostate Cancer: Data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916

PURPOSE: Prostate-specific antigen progression (PSA-P) is an indicator of progression in hormone-sensitive (HS) and castration-resistant (CR) prostate cancer (PC). We evaluated different definitions of PSA-P as predictors of overall survival (OS). PATIENTS AND METHODS: A total of 1,078 patients with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hussain, Maha, Goldman, Bryan, Tangen, Cathy, Higano, Celestia S., Petrylak, Daniel P., Wilding, George, Akdas, Atif M., Small, Eric J., Donnelly, Bryan J., Sundram, Subramanian Kanaga, Burch, Patrick A., DiPaola, Robert S., Crawford, E. David
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2009
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2684851/
https://ncbi.nlm.nih.gov/pubmed/19380444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.19.9810
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados